13 March 2020
Dear valued customer:
As a government quarantine or similar measure designed to limit the spread of the COVID-19 virus has been issued in one or more areas of your country, IDEXX has updated this page with relevant information and guidance.
We are here to help in any way we can. While the situation is highly dynamic, we are committed to providing you the products, services, and support you’ve come to trust. We are well-positioned generally to maintain your necessary supplies and services:
- You can continue to run in-clinic diagnostics on your IDEXX or other point-of-care instruments and rapid assays as usual, especially for urgent patients. We suggest keeping 4-6 weeks of consumables in inventory in case of transportation delays.
- With a global network of more than 80 laboratories worldwide, IDEXX is continuing to receive and process your patient samples across our network of IDEXX Reference Laboratories.
Please be aware that transportation delays caused by measures implemented by national, regional, and local governments may result in delays in turn-around times at IDEXX Reference Laboratories, as well as in shipping supplies to you. As of today, we are not aware of any systemic transportation delays. We will work to keep you updated if this should occur.
To support the health and safety of you, your clients and our IDEXX employees, during the quarantine period IDEXX will follow the guidance of local government and health authorities regarding travel and in person visits. So long as the government has approved travel within the country for business reasons, we remain available to visit. We also respect and will defer to your preference for meeting in person or remotely.